QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette
NEWCASTLE UPON TYNE, UK, Dec 17 (Bernama-GLOBE NEWSWIRE) —QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over £11 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC™ and disposable test cassette. QuantuMDx accelerated development, scale-up and…

